Luye expanding I-O deal with U.S. firm Elpis to focus on CAR T therapies

Life Science

Oncologie Launches with $16.5 Million for IO Combinations in China and the US

Life Science

Life Science & Technology Weekly 146 – Frontier Biotech’s HIV Drug Approved, First China-Developed HIV Treatment

Life Science, Technology

Hangzhou Just Biotherapeutics Secures $35 Million Series B+ Financing

Life Science

White House: Trump’s drug pricing plan will make the rest of the world pay its fair share

Life Science

Pot producer Aphria raising $225 million for expansions, facilities, possible acquisitions

Cannabis, Life Science

Frontier Biotech’s HIV Drug Approved, First China-Developed HIV Treatment

Life Science

Zhejiang Silk Road Joins In $100M Series B Round In British Surgical Robot Developer CMR Surgical

Life Science

China News Weekly 63 – China funds to boost support for domestic listings of tech giants: paper

Life Science, Technology

Hookipa Biotech and Gilead Ink Deal to Develop HIV and Hepatitis B Therapies

Life Science

CROP Acquires 30% Interest In State-Of-The-Art Washington Greenhouse

Cannabis, Life Science

Tricida Files $150M IPO, Shares Kidney Drug Trial Results

Life Science

AtriCure and Baheal Group Establish Partnership and China Distribution Agreement

Life Science

Quantum Surgical Raises Series A Capital from Ally Bridge

Life Science

Harbour BioMed Teams Up with Wistar to Discover Novel mAbs

Life Science